eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2019
vol. 15
 
Share:
Share:
abstract:
Original paper

Short-term stent coverage of second-generation zotarolimus-eluting durable polymer stents: Onyx one-month optical coherence tomography study

Tomasz Roleder
1
,
Elvin Kedhi
2
,
Balazs Berta
2
,
Pawel Gasior
1
,
Wojciech Wanha
1
,
Magda Roleder
1
,
Joanna Fluder
1
,
Grzegorz Smolka
1
,
Andrzej Ochala
1
,
Wojciech Wojakowski
1

  1. Department of Cardiology and Structural Heart Diseases, 3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland
  2. Isala Haartcentrum, Zwolle, Netherlands
Adv Interv Cardiol 2019; 15, 2 (56): 143–150
Online publish date: 2019/06/26
View full text Get citation
 
Introduction
To date the early strut coverage with the second-generation durable-polymer ONYX zotarolimus-eluting stent (O-ZES) is unknown.

Aim
Optical coherence tomography (OCT) assessed the strut coverage of O-ZES at thirty-day follow-up.

Material and methods
OCT was performed after implantation and at 1-month follow-up in 15 patients treated with O-ZES.

Results
Mean patient age was 67 ±7 years (73% males). The clinical presentation consisted of acute coronary syndromes (n = 13) and stable coronary disease (n = 2). Four (26%) patients had diabetes. OCT analysis was performed at baseline and 1-month follow-up in all stents. 378 cross-sections with 3582 struts were assessed at baseline and 3661 at follow-up. At follow-up, 88% struts were covered by tissue with a median thickness 37.91 µm (IQR: 22.32–64.15). Median in-stent area obstruction by neointima was 2.64% (IQR: 1.70–4.84). From the total stent covered area, 92.3% showed complete strut coverage. Homogeneous tissue was observed in 74% of cases. There were no differences in minimal lumen area (5.07 ±1.08 mm2 vs. 4.81 ±0.94 mm2, p = 0.125) or minimal stent area (4.95 ±1.22 mm2 vs. 4.92 ±0.99 mm2) at baseline and at follow-up. There were no differences in the rate of strut malapposition (4.3% vs. 5.7%, p = 0.417). For all stents, malapposition volume was 47.9 mm3 at baseline and 51.7 mm3 at follow-up, giving the late acquired stent malapposition volume of 3.8 mm3.

Conclusions
The second-generation durable polymer O-ZES showed favorable vessel healing at 30-day OCT follow-up.

keywords:

zotarolimus-eluting stent, vessel healing, optical coherence tomography, 1-month follow-up

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.